The genome editing market is projected to reach US$ 16,986.69 million by 2028 from US$ 5,199.40 million in 2021; it is expected to grow at a CAGR of 18.4% from 2021 to 2028.
Over the past few years, advances in genome editing technologies have been making constant headlines. Genome editing technologies can alter biological research and significantly impact human health, food security, and environmental sustainability since they are precise, relatively inexpensive, easy to use, and remarkably powerful. The advances in genome editing can be traced back to quiet beginnings in the 1990s. The introduction of CRISPR-Cas9 - a genome-editing tool that can be used to make precise and targeted changes in the DNA sequence with ease - is mainly responsible for the recent rise in the amount and scope of applications of genome editing technologies. The CRISPR platform's ease of use, as compared to previous technologies, has resulted in its widespread adoption and application. Genome editing could have a favorable impact on sustainable development, environmental management, food security, and the introduction of affordable diagnostics and therapies for various diseases due to these advancements.
A team from MIT and Harvard's Broad Institute has developed a novel CRISPR genome-editing technique that has the potential to fix up to 89% of disease-causing genetic abnormalities. CRISPR-Cas9 and reverse transcriptase, two of the most significant proteins in molecular biology, have been merged into a single machine by researchers. Prime editing is a method that can alter human cells directly in a precise, efficient, and highly versatile manner. They have also developed a CRISPR RNA-cutting enzyme into an antiviral agent that can be programmed to detect and eliminate RNA-based viruses in human cells. The Cas13 enzyme has previously been used to cut and alter human RNA and as a diagnostic approach for detecting the presence of viruses, bacteria, and other targets. This is one of the first studies to use Cas13, or any CRISPR system, as an antiviral in human cells in culture.
Recognizing the potential of genome editing techniques for studying and manipulating the genome., the Department of Biotechnology (DBT), Govt. of India has been fostering research and innovation in genome engineering technologies and applications to make them more accessible and inexpensive for research and development ( R&D). Through focused calls for proposals in different areas such as the development of new methods, tools, processes, and platforms for genome editing, improvement of existing genome-editing methods, and novel applications of genome editing technologies in agriculture, bioenergy, environmental research, and human health, efforts have been made to encourage R&D programs in emerging genome engineering technologies and their applications.
World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness Centers for Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC) are among the primary and secondary sources referred to while preparing the report on the genome editing market.
Reasons to Buy
Over the past few years, advances in genome editing technologies have been making constant headlines. Genome editing technologies can alter biological research and significantly impact human health, food security, and environmental sustainability since they are precise, relatively inexpensive, easy to use, and remarkably powerful. The advances in genome editing can be traced back to quiet beginnings in the 1990s. The introduction of CRISPR-Cas9 - a genome-editing tool that can be used to make precise and targeted changes in the DNA sequence with ease - is mainly responsible for the recent rise in the amount and scope of applications of genome editing technologies. The CRISPR platform's ease of use, as compared to previous technologies, has resulted in its widespread adoption and application. Genome editing could have a favorable impact on sustainable development, environmental management, food security, and the introduction of affordable diagnostics and therapies for various diseases due to these advancements.
A team from MIT and Harvard's Broad Institute has developed a novel CRISPR genome-editing technique that has the potential to fix up to 89% of disease-causing genetic abnormalities. CRISPR-Cas9 and reverse transcriptase, two of the most significant proteins in molecular biology, have been merged into a single machine by researchers. Prime editing is a method that can alter human cells directly in a precise, efficient, and highly versatile manner. They have also developed a CRISPR RNA-cutting enzyme into an antiviral agent that can be programmed to detect and eliminate RNA-based viruses in human cells. The Cas13 enzyme has previously been used to cut and alter human RNA and as a diagnostic approach for detecting the presence of viruses, bacteria, and other targets. This is one of the first studies to use Cas13, or any CRISPR system, as an antiviral in human cells in culture.
Recognizing the potential of genome editing techniques for studying and manipulating the genome., the Department of Biotechnology (DBT), Govt. of India has been fostering research and innovation in genome engineering technologies and applications to make them more accessible and inexpensive for research and development ( R&D). Through focused calls for proposals in different areas such as the development of new methods, tools, processes, and platforms for genome editing, improvement of existing genome-editing methods, and novel applications of genome editing technologies in agriculture, bioenergy, environmental research, and human health, efforts have been made to encourage R&D programs in emerging genome engineering technologies and their applications.
World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness Centers for Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC) are among the primary and secondary sources referred to while preparing the report on the genome editing market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the genome editing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global genome editing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Genome Editing Market- By Technology
1.3.2 Genome Editing Market- By Application
1.3.3 Genome Editing Market- By End User
1.3.4 Genome Editing Market- By Geography
2. Genome Editing Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Genome Editing Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion
5. Genome Editing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
5.1.2 Continuous Technological Advancements in Gene-Editing Tools
5.2 Market Restraints
5.2.1 High Cost of Genomic Equipment
5.3 Market Opportunities
5.3.1 Developing Biotechnology Industry in Emerging Regions
5.4 Future Trends
5.4.1 Technological Innovations
5.5 Impact Analysis
6. Genome Editing Market- Global Analysis
6.1 Global Genome Editing Market Revenue Forecast and Analysis
6.2 Global Genome Editing Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Genome Editing Market Revenue and Forecasts To 2028- by Technology
7.1 Overview
7.2 Global Genome Editing Market, By Technology, 2021 & 2028 (%)
7.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
7.3.1 Overview
7.3.2 CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.4 TALEN
7.4.1 Overview
7.4.2 TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.5 Antisense
7.5.1 Overview
7.5.2 Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8. Genome Editing Market Revenue and Forecasts To 2028 - Application
8.1 Overview
8.2 Global Genome Editing Market Share, By Application - 2021 & 2028 (%)
8.3 Cell Line Engineering
8.3.1 Overview
8.3.2 Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Genetic Engineering
8.4.1 Overview
8.4.2 Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Applications
8.5.1 Overview
8.5.2 Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Discovery
8.6.1 Overview
8.6.2 Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9. Genome Editing Market Revenue and Forecasts To 2028 - End User
9.1 Overview
9.2 Global Genome Editing Market Share by End User - 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinical Research Organizations (CRO’s)
9.4.1 Overview
9.4.2 Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10. Genome Editing Market Revenue and Forecasts to 2028 - Geographical Analysis
10.1 North America: Genome Editing Market
10.1.1 Overview
10.1.2 North America: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Genome Editing Market, by Technology, 2019-2028 (US$ Million)
10.1.4 North America: Genome Editing Market, by Applications, 2019-2028 (US$ Million)
10.1.5 North America: Genome Editing Market, End User, 2019-2028 (US$ Million)
10.1.6 North America: Genome Editing Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Genome Editing Market, by Technology, 2019-2028 (US$ Million)
10.1.6.1.4 US: Genome Editing Market, by Applications, 2019-2028 (US$ Million)
10.1.6.1.5 US: Genome Editing Market, End User, 2019-2028 (US$ Million)
10.1.6.2 Canada: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Genome Editing Market, by Technology, 2019-2028 (US$ Million)
10.1.6.2.4 Canada: Genome Editing Market, by Applications, 2019-2028 (US$ Million)
10.1.6.2.5 Canada: Genome Editing Market, End User, 2019-2028 (US$ Million)
10.1.6.3 Mexico: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Genome Editing Market, by Technology, 2019-2028 (US$ Million)
10.1.6.3.4 Mexico: Genome Editing Market, by Applications, 2019-2028 (US$ Million)
10.1.6.3.5 Mexico: Genome Editing Market, End User, 2019-2028 (US$ Million)
10.2 Europe: Genome Editing Market
10.2.1 Overview
10.2.2 Europe: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
10.2.4.1 Europe: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
10.2.5.1 Germany: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.1.1 Overview
10.2.5.1.2 Germany: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.1.3 Germany: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.5.1.4 Germany: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
10.2.5.1.5 Germany: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.5.2 France: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.2.1 Overview
10.2.5.2.2 France: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.2.3 France: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.5.2.4 France: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
10.2.5.2.5 France: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.5.3 UK: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.3.1 Overview
10.2.5.3.2 UK: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.3.3 UK: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.5.3.4 UK: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
10.2.5.3.5 UK: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.5.4 Italy: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.4.1 Overview
10.2.5.4.2 Italy: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.4.3 Italy: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.5.4.4 Italy: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
10.2.5.4.5 Italy: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.5.5 Spain: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.5.1 Overview
10.2.5.5.2 Spain: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.5.3 Spain: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.5.5.4 Spain: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
10.2.5.5.5 Spain: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.5.6 Rest of Europe: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.6.1 Overview
10.2.5.6.2 Rest of Europe: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.5.6.3 Rest of Europe: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.5.6.4 Rest of Europe: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
10.2.5.6.5 Rest of Europe: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific: Genome Editing Market Revenue and Forecast to 2028
10.3.1 Overview
10.3.2 Asia Pacific: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.4 Asia Pacific: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.5 Asia Pacific: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6 Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.4 China: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.5 China: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.2 Japan: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.4 Japan: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.5 Japan: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.3 India: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.4 India: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.5 India: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.4 South Korea: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.4 South Korea: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.5 South Korea: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.5 Australia: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.4 Australia: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.5 Australia: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.4 Middle East & Africa Genome Editing Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Genome Editing Market Revenue and Forecast to 2028, Technology (US$ Million)
10.4.4 Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
10.4.4.1 Middle East & Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.4.5 Middle East & Africa: Genome Editing Market, by Country, 2021 & 2028 (%)
10.4.5.1 UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.1.3 UAE: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.4.5.1.4 UAE: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.4.5.1.5 UAE: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.4.5.2 Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.2.3 Saudi Arabia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.4.5.2.4 Saudi Arabia: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.4.5.2.5 Saudi Arabia: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.4.5.3 South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.3.3 South Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.4.5.3.4 South Africa: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.4.5.3.5 South Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.4.5.4 Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.4.3 Rest of Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.4.5.4.4 Rest of Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.4.5.4.5 Rest of Middle East and Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.5 South and Central America: Genome Editing Market Revenue and Forecast To 2028
10.5.1 Overview
10.5.2 South and Central America: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.5.4 South and Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
10.5.5 South and Central America: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.5.6 South and Central America: Genome Editing Market, by Country, 2021 & 2028 (%)
10.5.6.1 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.4 Argentina: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.5.6.1.5 Argentina: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.4 Brazil: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.5.6.2.5 Brazil: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Genome Editing Market- Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Genome Editing Market- Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.3 Rest of South & Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.5.6.3.5 Rest of South and Central America: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Genome Editing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Genome Editing Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Horizon Discovery Group plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GenScript
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CRISPR Therapeutics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Editas Medicine
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of TermsList of Tables
Table 1. North America Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Genome Editing Market, End User- Revenue and Forecast to 2028 (US$ Million)
Table 4. US Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 6. US Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. France: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 20. France: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 21. France: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 37. China: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 38. China: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 39. China: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 43. India: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 44. India: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 45. India: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 55. Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 56. Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East & Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 59. UAE: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 60. UAE: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 61. Saudi Arabia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 62. Saudi Arabia: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 63. Saudi Arabia: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 64. South Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 65. South Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 66. South Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Middle East and Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 71. South and Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 72. South and Central America: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 73. Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 74. Argentina: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 75. Argentina: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 76. Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 77. Brazil: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 78. Brazil: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of South & Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of South & Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South and Central America: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 82. Organic Developments Done by Companies
Table 83. Inorganic Developments Done by Companies
Table 84. Glossary of Terms, Genome Editing MarketList of Figures
Figure 1. Genome Editing Market Segmentation
Figure 2. Cell Therapy Bioprocessing Segmentation, By Region
Figure 3. Global Genome Editing Market Overview
Figure 4. CRISPR Held Largest Share of Technology Segment in Genome Editing Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Genome Editing Market, by Geography (US$ Million)
Figure 7. Global Genome Editing Market- Leading Country Markets (US$ Million)
Figure 8. Global Genome Editing Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Expert Opinion
Figure 15. Genome Editing Market Impact Analysis of Drivers and Restraints
Figure 16. Global Genome Editing Market- Revenue Forecast and Analysis - 2020-2028
Figure 17. Global Genome Editing Market- By Geography Forecast and Analysis - 2020-2028
Figure 18. Market Positioning of Key Players in Global Genome Editing Market
Figure 19. Global Genome Editing Market, by Technology, 2021 & 2028 (%)
Figure 20. CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Global Genome Editing Market Share, by Application - 2021 & 2028 (%)
Figure 25. Cell Line Engineering: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Genetic Engineering: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Diagnostic Applications: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Drug Discovery: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Others: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Global Genome Editing Market Share by End User - 2021 & 2028 (%)
Figure 31. Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Clinical Research Organizations: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Academic and Research Institutes: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. North America: Genome Editing Market, by Key Country - Revenue (2021) (US$ Million)
Figure 35. North America Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 37. US: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Canada: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Mexico: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Europe: Genome Editing Market, by Key Country - Revenue (2021) (US$ Million)
Figure 41. Europe: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 43. Germany: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. France: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. UK: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Italy: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Spain: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Rest of Europe: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Asia Pacific: Genome Editing Market, by Key Country - Revenue (2021) (US$ Million)
Figure 50. Asia Pacific: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 51. Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 52. China: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 53. Japan: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 54. India: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 55. South Korea: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 56. Australia: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 57. Rest of Asia Pacific: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 58. Middle East & Africa Genome Editing Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 59. Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. Middle East & Africa: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 61. UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 64. Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 65. South and Central America: Genome Editing Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 66. South and Central America: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 67. South and Central America: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 68. Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 69. Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 70. Rest of South and Central America: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
Figure 71. Impact of COVID-19 Pandemic in North American Country Markets
Figure 72. Impact of COVID-19 Pandemic in European Country Markets
Figure 73. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 74. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 75. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 76. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
- Lonza
- Horizon Discovery Group plc.
- Integrated DNA Technologies
- GenScript
- New England Biolabs
- Eurofins Scientific
- CRISPR Therapeutics
- Editas Medicine
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 176 |
| Published | January 2022 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 5199.4 million |
| Forecasted Market Value ( USD | $ 16986.69 million |
| Compound Annual Growth Rate | 18.4% |
| Regions Covered | Global |
